Abbott Labs (ABT) Puts Active After Q4 Earnings

Shares in Abbott Laboratories (ABT) are in negative territory on Wednesday after the company reported better than expected fourth-quarter earnings, but revenue that was less than analysts estimated. Shares in the medical products company dropped 5.5% to an intraday low of $36.94 near the open, but have rallied significantly during the session to stand at […] View the full post at: Abbott Labs (ABT) Puts Active After Q4 Earnings Related posts: Lennar Spikes on Call Activity? 4Kids Entertainment Puts Itself Up for Sale FDA Panel Votes in Favor of Effectiveness of Forest Labs’ Daxas